Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study (PLoS One (2017) 12:9 (e0184550) DOI: 10.1371/journal.pone.0184550)

  1. Buti, M.
  2. Manzano, M.L.
  3. Morillas, R.M.
  4. García-Retortillo, M.
  5. Martín, L.
  6. Prieto, M.
  7. Gutiérrez, M.L.
  8. Suárez, E.
  9. Gómez Rubio, M.
  10. López, J.
  11. Castillo, P.
  12. Rodríguez, M.
  13. Zozaya, J.M.
  14. Simón, M.A.
  15. Morano, L.E.
  16. Calleja, J.L.
  17. Yébenes, M.
  18. Esteban, R.
Journal:
PLoS ONE

ISSN: 1932-6203

Year of publication: 2018

Volume: 13

Issue: 6

Type: Erratum

DOI: 10.1371/JOURNAL.PONE.0199926 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus